Long-term outcomes of fludarabine, melphalan and antithymocyte globulin as reduced-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with primary immunodeficiency disorders: a prospective single center study
Amir Ali Hamidieh(Stem Cell Technology Research Center), Ardeshir Ghavamzadeh(Tehran University of Medical Sciences), Sara Faghihi‐Kashani(San Francisco VA Medical Center), Maryam Behfar(Tehran University of Medical Sciences), Zahra Pourpak(Children's Medical Center), M. R. Mozafari(Monash University), Masoud Movahedi(Tehran University of Medical Sciences), Mostafa Moin(Children's Medical Center), A S Hosseini(Tehran University of Medical Sciences), Mohammad Reza Fazlollahi(Tehran University of Medical Sciences)
Cited by 19
Related Papers
Liposomes: A Review of Manufacturing Techniques and Targeting Strategies
|Current Nanoscience|2011|354
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors
|Haematologica|2021|236
Safety and Efficacy of Nanocurcumin as Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial
|Neurotherapeutics|2018|142
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis Congenita
|Biology of Blood and Marrow Transplantation|2013|130
Fourth Update on the Iranian National Registry of Primary Immunodeficiencies: Integration of Molecular Diagnosis
|Journal of Clinical Immunology|2018|106